Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cigna Corp (CI)
NYSE:CI
Holding CI?
Track your performance easily
Earnings Data
Report Date
Jan 31, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$7.83Last Year’s EPS
$6.79Same Quarter Last Year
Strong Buy
Based on 14 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 31, 2024
|% Change Since: -11.80%
|Next Earnings Date:Jan 31, 2025
Earnings Call Sentiment|Positive
The earnings call conveyed a positive outlook with strong financial performance in the third quarter, driven by Evernorth's growth and strategic innovations. However, challenges such as the investment loss in VillageMD and elevated medical costs were noted.Company Guidance
In the third quarter earnings call for Cigna Group (CI) on October 31, 2024, the company provided several key metrics and forward-looking guidance. Cigna reported a total revenue of $63.7 billion and adjusted earnings per share (EPS) of $7.51 for Q3. The company maintained its full-year 2024 adjusted EPS outlook of at least $28.40, reflecting over 13% year-over-year growth. Cigna highlighted the strong performance of its Evernorth segment, particularly in Specialty and Care Services, which saw a 23% revenue growth. The company also discussed its capital deployment strategy, noting $5.7 billion in share repurchases year-to-date. For 2025, Cigna expects EPS growth of at least 10%, supported by continued biosimilar adoption and the sale proceeds from its Medicare Advantage business, despite headwinds such as the absence of VillageMD dividends and some stranded overhead costs.Strong Third Quarter Financial Performance
The Cigna Group reported total revenue of $63.7 billion and adjusted earnings per share of $7.51, demonstrating strong financial performance and meeting financial commitments.
Evernorth Growth
Evernorth contributed significantly with a revenue of $52.5 billion and pretax adjusted earnings growing by 9% to $1.9 billion. This was driven by innovations and growth in specialty and care services.
Specialty and Care Services Surge
Specialty and Care Services revenue grew by 23% in the quarter, driven by a rapid uptake of specialty medications and the adoption of HUMIRA biosimilars.
Robust Capital Management
Cigna has repurchased approximately 16.9 million shares for about $5.7 billion year-to-date, demonstrating confidence in their business strength and sustainable growth.
Expansion of EnCircleRx Program
The EnCircleRx program has grown to cover almost 8 million lives, reflecting strong demand and adoption.
---
CI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 31, 2024 | $311.58 | $313.49 | +0.61% |
| Aug 01, 2024 | $345.88 | $329.94 | -4.61% |
| May 02, 2024 | $352.87 | $340.34 | -3.55% |
| Feb 02, 2024 | $302.35 | $318.60 | +5.37% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cigna Corp (CI) report earnings?
Cigna Corp (CI) is schdueled to report earning on Jan 31, 2025, TBA Not Confirmed.
What is Cigna Corp (CI) earnings time?
Cigna Corp (CI) earnings time is at Jan 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CI EPS forecast?
CI EPS forecast for the fiscal quarter 2024 (Q4) is $7.83.
---
